Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ASCVD”

131 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 131 results

Not applicableLooking for participantsNCT07315997
What this trial is testing

The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

Who this might be right for
Rheumatoid Arthritis (RAAtherosclerotic Cardiovascular Disease (ASCVD)
Brigham and Women's Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Not applicableNot Yet RecruitingNCT07462871
What this trial is testing

Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health

Who this might be right for
Atherosclerosis Cardiovascular DiseaseMetabolic SyndromeDyslipidaemia
Liverpool John Moores University 30
Testing effectiveness (Phase 2)Study completedNCT04992065
What this trial is testing

A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novo Nordisk A/S 267
Not applicableNot Yet RecruitingNCT07594392
What this trial is testing

Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE

Who this might be right for
Atherosclerotic Cardiovascular Disease
St. Jude Children's Research Hospital 650
Not applicableUnknownNCT05434273
What this trial is testing

Effects of Integrated Cardiovascular Health Education Program on Older Adults at Risk of ASCVD

Who this might be right for
Cardiovascular DiseasesHealthy LifestyleHealth Education
The Hong Kong Polytechnic University 190
Large-scale testing (Phase 3)Study completedNCT03814187
What this trial is testing

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

Who this might be right for
ASCVDElevated CholesterolHeterozygous Familial Hypercholesterolemia+1 more
Novartis Pharmaceuticals 3,275
Not applicableUnknownNCT06406998
What this trial is testing

Maternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVD

Who this might be right for
Cardiovascular DiseasesAtherosclerosisPregnancy Complications+2 more
Samsung Medical Center 5,461,222
Not applicableLooking for participantsNCT05765370
What this trial is testing

LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)

Who this might be right for
Atherosclerotic Cardiovascular DiseaseOlder PatientsLDL Cholesterol
China National Center for Cardiovascular Diseases 4,200
Not applicableNot Yet RecruitingNCT07355894
What this trial is testing

Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Coronary Artery Calcification
Stanford University 120,000
Not applicableStudy completedNCT07196280
What this trial is testing

Protective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK Biobank Cohort and Chinese Single Center Database Studies

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Benign Prostatic Hypertrophy (BPH)
Chinese PLA General Hospital 10,000
Not applicableActive Not RecruitingNCT07615179
What this trial is testing

Alirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD)

Who this might be right for
Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events
Sanofi 2,214
Testing effectiveness (Phase 2)Looking for participantsNCT07303777
What this trial is testing

Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

Who this might be right for
Atherosclerosis Cardiovascular DiseaseASCVDASCVD Management
Atom Therapeutics Co., Ltd 200
Not applicableEnded earlyNCT04197453
What this trial is testing

The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)

Who this might be right for
ASCVD
Amgen 752
Not applicableNot Yet RecruitingNCT07615296
What this trial is testing

Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and Cost-Effectiveness Assessment

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Beijing Anzhen Hospital 6,000
Not applicableActive Not RecruitingNCT05726838
What this trial is testing

The Belgian REAL (BE.REAL) Registry

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 600
Not applicableLooking for participantsNCT06858332
What this trial is testing

Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 2,382
Not applicableEnded earlyNCT05834673
What this trial is testing

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Coronary Heart Disease (CHD)Cerebrovascular Disease+1 more
Monash University 6
Not applicableEnded earlyNCT05745272
What this trial is testing

Cardiovascular Risk Categories and Attaining LDL-C Targets in Middle Eastern Adults Aged 30-55 Years of Age

Who this might be right for
Atherosclerotic Cardiovascular RiskLow-density-lipoprotein (LDL) Cholesterol
Jordan Collaborating Cardiology Group 1,000
Not applicableNot Yet RecruitingNCT07322510
What this trial is testing

HEARTS in Sync + CardioWatch 287-2

Who this might be right for
Wearable DeviceCardiovascular DiseaseASCVD Management+1 more
Nova Scotia Health Authority 216
Load More Results